Pfizer C4931008

Es posible que algunos contenidos no estén disponibles en español.

Study Details

Full Title

A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE
SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT
PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

Principal Investigator

Michael

Smith

Protocol Number

PRO00119924

Phase

III

Enrollment Status

Open to Enrollment